Loading…
Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction
The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year cas...
Saved in:
Published in: | The American surgeon 2012-09, Vol.78 (9), p.936-941 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3 |
container_end_page | 941 |
container_issue | 9 |
container_start_page | 936 |
container_title | The American surgeon |
container_volume | 78 |
creator | DUCHESNE, Juan C GUIDRY, Chrissy HOFFMAN, Jordan R. H PARK, Timothy S BOCK, Jiselle LAWSON, Sarah MEADE, Peter MCSWAIN, Norman E |
description | The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year case-control study was conducted to determine the impact on mortality of LVR versus conventional resuscitation efforts (CRE) during HCRR. A total of 45 patients managed with a HCRR + LVR protocol (combination Hextend® and 3% hypertonic saline) and 55 historical cohorts managed with HCRR + CRE (lactated Ringer's) were included. Patient demographics, number of intraoperative units of packed red blood cells (PRBCs) and fresh-frozen plasma (FFP) received, and FFP:PRBC ratio were similar between groups. The mean intraoperative fluid volume was 0.76 L in the HCRR + LVR group versus 4.7 L in the HCRR + CRE group (P = 0.003). In a linear regression model HCRR + LVR versus HCRR + CRE, mean trauma intensive care unit length of stay was 6 versus 11 days (P = 0.009); 30-day overall mortality was 11.1 versus 32.7 per cent (P = 0.009); perioperative mortality was 2.2 to 10.9 per cent (P = 0.13); and intensive care unit mortality 8.8 to 21.8 per cent (P = 0.07). LVR protocol conveyed a survival benefit to patients undergoing HCRR (odds ratio for mortality, 0.07 [95% confidence interval 0.07-0.54]). This is the first civilian study to analyze the impact of LVR in patients managed with HCRR during IOH. Patients with IOH managed with HCRR and a predefined LVR protocol with Hextend® and 3 per cent hypertonic saline had an overall survival advantage and shorter trauma intensive care unit length of stay. LVR can be an effective alternative to CRE when used in combination with HCRR in patients with IOH. |
doi_str_mv | 10.1177/000313481207800931 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1039205401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1039205401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3</originalsourceid><addsrcrecordid>eNpl0F1LHDEUBuBQKnW1_QO9kEAp9GbqSTLJJL0TWz9gQeiqV8KQzZ64IzOTNZlR_PfNuquCvQqHPOfl8BLylcFPxqrqEAAEE6VmHCoNYAT7QCZMSlkYzcVHMlmDYi12yV5Kd3kslWSfyC7nRpUcYEJupuGxuA7t2CH9i2lMrhns0ISe-hDpDB8wIj3vh2jDCmP-eUB6hl2IcWlv8Rc9orMBV7Tp6bDMCc3tcqC_m4hunfGZ7HjbJvyyfffJ1cmfy-OzYnpxen58NC2c4MAKXy24UAy99mJhhRLGgTOoTVkx5o2W1qtSlxKkVTo7rvlciNJp78RcAop98mOTu4rhfsQ01F2THLat7TGMqWYgDAdZAsv02zt6F8bY5-uelTKKCciKb5SLIaWIvl7FprPxKaN63X39f_d56WAbPc47XLyuvJSdwfctsMnZ1kfbuya9OcWNqSQT_wAagokp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1039696130</pqid></control><display><type>article</type><title>Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction</title><source>Sage Journals Online</source><creator>DUCHESNE, Juan C ; GUIDRY, Chrissy ; HOFFMAN, Jordan R. H ; PARK, Timothy S ; BOCK, Jiselle ; LAWSON, Sarah ; MEADE, Peter ; MCSWAIN, Norman E</creator><creatorcontrib>DUCHESNE, Juan C ; GUIDRY, Chrissy ; HOFFMAN, Jordan R. H ; PARK, Timothy S ; BOCK, Jiselle ; LAWSON, Sarah ; MEADE, Peter ; MCSWAIN, Norman E</creatorcontrib><description>The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year case-control study was conducted to determine the impact on mortality of LVR versus conventional resuscitation efforts (CRE) during HCRR. A total of 45 patients managed with a HCRR + LVR protocol (combination Hextend® and 3% hypertonic saline) and 55 historical cohorts managed with HCRR + CRE (lactated Ringer's) were included. Patient demographics, number of intraoperative units of packed red blood cells (PRBCs) and fresh-frozen plasma (FFP) received, and FFP:PRBC ratio were similar between groups. The mean intraoperative fluid volume was 0.76 L in the HCRR + LVR group versus 4.7 L in the HCRR + CRE group (P = 0.003). In a linear regression model HCRR + LVR versus HCRR + CRE, mean trauma intensive care unit length of stay was 6 versus 11 days (P = 0.009); 30-day overall mortality was 11.1 versus 32.7 per cent (P = 0.009); perioperative mortality was 2.2 to 10.9 per cent (P = 0.13); and intensive care unit mortality 8.8 to 21.8 per cent (P = 0.07). LVR protocol conveyed a survival benefit to patients undergoing HCRR (odds ratio for mortality, 0.07 [95% confidence interval 0.07-0.54]). This is the first civilian study to analyze the impact of LVR in patients managed with HCRR during IOH. Patients with IOH managed with HCRR and a predefined LVR protocol with Hextend® and 3 per cent hypertonic saline had an overall survival advantage and shorter trauma intensive care unit length of stay. LVR can be an effective alternative to CRE when used in combination with HCRR in patients with IOH.</description><identifier>ISSN: 0003-1348</identifier><identifier>EISSN: 1555-9823</identifier><identifier>DOI: 10.1177/000313481207800931</identifier><identifier>PMID: 22964200</identifier><identifier>CODEN: AMSUAW</identifier><language>eng</language><publisher>Atlanta, GA: Southeastern Surgical Congress</publisher><subject><![CDATA[Biological and medical sciences ; Blood banks ; Blood Loss, Surgical - mortality ; Blood Loss, Surgical - prevention & control ; Case-Control Studies ; Erythrocyte Transfusion ; Female ; Fluid Therapy - methods ; General aspects ; Hemodynamics - physiology ; Hemorrhage - mortality ; Hemorrhage - prevention & control ; Hemostatic Techniques ; Hospitals ; Humans ; Hydroxyethyl Starch Derivatives - administration & dosage ; Intensive care ; Intensive Care Units - statistics & numerical data ; Isotonic Solutions - administration & dosage ; Length of Stay - statistics & numerical data ; Linear Models ; Male ; Medical sciences ; Middle Aged ; Mortality ; Plasma ; Plasma Substitutes - administration & dosage ; Respiratory distress syndrome ; Resuscitation - methods ; Saline Solution, Hypertonic - administration & dosage ; Survival Analysis ; Treatment Outcome]]></subject><ispartof>The American surgeon, 2012-09, Vol.78 (9), p.936-941</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright Southeastern Surgical Congress Sep 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3</citedby><cites>FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26299751$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22964200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DUCHESNE, Juan C</creatorcontrib><creatorcontrib>GUIDRY, Chrissy</creatorcontrib><creatorcontrib>HOFFMAN, Jordan R. H</creatorcontrib><creatorcontrib>PARK, Timothy S</creatorcontrib><creatorcontrib>BOCK, Jiselle</creatorcontrib><creatorcontrib>LAWSON, Sarah</creatorcontrib><creatorcontrib>MEADE, Peter</creatorcontrib><creatorcontrib>MCSWAIN, Norman E</creatorcontrib><title>Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction</title><title>The American surgeon</title><addtitle>Am Surg</addtitle><description>The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year case-control study was conducted to determine the impact on mortality of LVR versus conventional resuscitation efforts (CRE) during HCRR. A total of 45 patients managed with a HCRR + LVR protocol (combination Hextend® and 3% hypertonic saline) and 55 historical cohorts managed with HCRR + CRE (lactated Ringer's) were included. Patient demographics, number of intraoperative units of packed red blood cells (PRBCs) and fresh-frozen plasma (FFP) received, and FFP:PRBC ratio were similar between groups. The mean intraoperative fluid volume was 0.76 L in the HCRR + LVR group versus 4.7 L in the HCRR + CRE group (P = 0.003). In a linear regression model HCRR + LVR versus HCRR + CRE, mean trauma intensive care unit length of stay was 6 versus 11 days (P = 0.009); 30-day overall mortality was 11.1 versus 32.7 per cent (P = 0.009); perioperative mortality was 2.2 to 10.9 per cent (P = 0.13); and intensive care unit mortality 8.8 to 21.8 per cent (P = 0.07). LVR protocol conveyed a survival benefit to patients undergoing HCRR (odds ratio for mortality, 0.07 [95% confidence interval 0.07-0.54]). This is the first civilian study to analyze the impact of LVR in patients managed with HCRR during IOH. Patients with IOH managed with HCRR and a predefined LVR protocol with Hextend® and 3 per cent hypertonic saline had an overall survival advantage and shorter trauma intensive care unit length of stay. LVR can be an effective alternative to CRE when used in combination with HCRR in patients with IOH.</description><subject>Biological and medical sciences</subject><subject>Blood banks</subject><subject>Blood Loss, Surgical - mortality</subject><subject>Blood Loss, Surgical - prevention & control</subject><subject>Case-Control Studies</subject><subject>Erythrocyte Transfusion</subject><subject>Female</subject><subject>Fluid Therapy - methods</subject><subject>General aspects</subject><subject>Hemodynamics - physiology</subject><subject>Hemorrhage - mortality</subject><subject>Hemorrhage - prevention & control</subject><subject>Hemostatic Techniques</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hydroxyethyl Starch Derivatives - administration & dosage</subject><subject>Intensive care</subject><subject>Intensive Care Units - statistics & numerical data</subject><subject>Isotonic Solutions - administration & dosage</subject><subject>Length of Stay - statistics & numerical data</subject><subject>Linear Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Plasma</subject><subject>Plasma Substitutes - administration & dosage</subject><subject>Respiratory distress syndrome</subject><subject>Resuscitation - methods</subject><subject>Saline Solution, Hypertonic - administration & dosage</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0003-1348</issn><issn>1555-9823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpl0F1LHDEUBuBQKnW1_QO9kEAp9GbqSTLJJL0TWz9gQeiqV8KQzZ64IzOTNZlR_PfNuquCvQqHPOfl8BLylcFPxqrqEAAEE6VmHCoNYAT7QCZMSlkYzcVHMlmDYi12yV5Kd3kslWSfyC7nRpUcYEJupuGxuA7t2CH9i2lMrhns0ISe-hDpDB8wIj3vh2jDCmP-eUB6hl2IcWlv8Rc9orMBV7Tp6bDMCc3tcqC_m4hunfGZ7HjbJvyyfffJ1cmfy-OzYnpxen58NC2c4MAKXy24UAy99mJhhRLGgTOoTVkx5o2W1qtSlxKkVTo7rvlciNJp78RcAop98mOTu4rhfsQ01F2THLat7TGMqWYgDAdZAsv02zt6F8bY5-uelTKKCciKb5SLIaWIvl7FprPxKaN63X39f_d56WAbPc47XLyuvJSdwfctsMnZ1kfbuya9OcWNqSQT_wAagokp</recordid><startdate>201209</startdate><enddate>201209</enddate><creator>DUCHESNE, Juan C</creator><creator>GUIDRY, Chrissy</creator><creator>HOFFMAN, Jordan R. H</creator><creator>PARK, Timothy S</creator><creator>BOCK, Jiselle</creator><creator>LAWSON, Sarah</creator><creator>MEADE, Peter</creator><creator>MCSWAIN, Norman E</creator><general>Southeastern Surgical Congress</general><general>SAGE PUBLICATIONS, INC</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7QL</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>201209</creationdate><title>Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction</title><author>DUCHESNE, Juan C ; GUIDRY, Chrissy ; HOFFMAN, Jordan R. H ; PARK, Timothy S ; BOCK, Jiselle ; LAWSON, Sarah ; MEADE, Peter ; MCSWAIN, Norman E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biological and medical sciences</topic><topic>Blood banks</topic><topic>Blood Loss, Surgical - mortality</topic><topic>Blood Loss, Surgical - prevention & control</topic><topic>Case-Control Studies</topic><topic>Erythrocyte Transfusion</topic><topic>Female</topic><topic>Fluid Therapy - methods</topic><topic>General aspects</topic><topic>Hemodynamics - physiology</topic><topic>Hemorrhage - mortality</topic><topic>Hemorrhage - prevention & control</topic><topic>Hemostatic Techniques</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hydroxyethyl Starch Derivatives - administration & dosage</topic><topic>Intensive care</topic><topic>Intensive Care Units - statistics & numerical data</topic><topic>Isotonic Solutions - administration & dosage</topic><topic>Length of Stay - statistics & numerical data</topic><topic>Linear Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Plasma</topic><topic>Plasma Substitutes - administration & dosage</topic><topic>Respiratory distress syndrome</topic><topic>Resuscitation - methods</topic><topic>Saline Solution, Hypertonic - administration & dosage</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DUCHESNE, Juan C</creatorcontrib><creatorcontrib>GUIDRY, Chrissy</creatorcontrib><creatorcontrib>HOFFMAN, Jordan R. H</creatorcontrib><creatorcontrib>PARK, Timothy S</creatorcontrib><creatorcontrib>BOCK, Jiselle</creatorcontrib><creatorcontrib>LAWSON, Sarah</creatorcontrib><creatorcontrib>MEADE, Peter</creatorcontrib><creatorcontrib>MCSWAIN, Norman E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Family Health Database (Proquest)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The American surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DUCHESNE, Juan C</au><au>GUIDRY, Chrissy</au><au>HOFFMAN, Jordan R. H</au><au>PARK, Timothy S</au><au>BOCK, Jiselle</au><au>LAWSON, Sarah</au><au>MEADE, Peter</au><au>MCSWAIN, Norman E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction</atitle><jtitle>The American surgeon</jtitle><addtitle>Am Surg</addtitle><date>2012-09</date><risdate>2012</risdate><volume>78</volume><issue>9</issue><spage>936</spage><epage>941</epage><pages>936-941</pages><issn>0003-1348</issn><eissn>1555-9823</eissn><coden>AMSUAW</coden><abstract>The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year case-control study was conducted to determine the impact on mortality of LVR versus conventional resuscitation efforts (CRE) during HCRR. A total of 45 patients managed with a HCRR + LVR protocol (combination Hextend® and 3% hypertonic saline) and 55 historical cohorts managed with HCRR + CRE (lactated Ringer's) were included. Patient demographics, number of intraoperative units of packed red blood cells (PRBCs) and fresh-frozen plasma (FFP) received, and FFP:PRBC ratio were similar between groups. The mean intraoperative fluid volume was 0.76 L in the HCRR + LVR group versus 4.7 L in the HCRR + CRE group (P = 0.003). In a linear regression model HCRR + LVR versus HCRR + CRE, mean trauma intensive care unit length of stay was 6 versus 11 days (P = 0.009); 30-day overall mortality was 11.1 versus 32.7 per cent (P = 0.009); perioperative mortality was 2.2 to 10.9 per cent (P = 0.13); and intensive care unit mortality 8.8 to 21.8 per cent (P = 0.07). LVR protocol conveyed a survival benefit to patients undergoing HCRR (odds ratio for mortality, 0.07 [95% confidence interval 0.07-0.54]). This is the first civilian study to analyze the impact of LVR in patients managed with HCRR during IOH. Patients with IOH managed with HCRR and a predefined LVR protocol with Hextend® and 3 per cent hypertonic saline had an overall survival advantage and shorter trauma intensive care unit length of stay. LVR can be an effective alternative to CRE when used in combination with HCRR in patients with IOH.</abstract><cop>Atlanta, GA</cop><pub>Southeastern Surgical Congress</pub><pmid>22964200</pmid><doi>10.1177/000313481207800931</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-1348 |
ispartof | The American surgeon, 2012-09, Vol.78 (9), p.936-941 |
issn | 0003-1348 1555-9823 |
language | eng |
recordid | cdi_proquest_miscellaneous_1039205401 |
source | Sage Journals Online |
subjects | Biological and medical sciences Blood banks Blood Loss, Surgical - mortality Blood Loss, Surgical - prevention & control Case-Control Studies Erythrocyte Transfusion Female Fluid Therapy - methods General aspects Hemodynamics - physiology Hemorrhage - mortality Hemorrhage - prevention & control Hemostatic Techniques Hospitals Humans Hydroxyethyl Starch Derivatives - administration & dosage Intensive care Intensive Care Units - statistics & numerical data Isotonic Solutions - administration & dosage Length of Stay - statistics & numerical data Linear Models Male Medical sciences Middle Aged Mortality Plasma Plasma Substitutes - administration & dosage Respiratory distress syndrome Resuscitation - methods Saline Solution, Hypertonic - administration & dosage Survival Analysis Treatment Outcome |
title | Low-Volume Resuscitation for Severe Intraoperative Hemorrhage: A Step in the Right Direction |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T17%3A51%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-Volume%20Resuscitation%20for%20Severe%20Intraoperative%20Hemorrhage:%20A%20Step%20in%20the%20Right%20Direction&rft.jtitle=The%20American%20surgeon&rft.au=DUCHESNE,%20Juan%20C&rft.date=2012-09&rft.volume=78&rft.issue=9&rft.spage=936&rft.epage=941&rft.pages=936-941&rft.issn=0003-1348&rft.eissn=1555-9823&rft.coden=AMSUAW&rft_id=info:doi/10.1177/000313481207800931&rft_dat=%3Cproquest_cross%3E1039205401%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3201-f7d2361ef8f3da3639c0c9e894711f985af6484505a6861e282b334c8fc3b50e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1039696130&rft_id=info:pmid/22964200&rfr_iscdi=true |